We are live on ! Find out more
VC

Voss Capital Portfolio holdings

AUM $1.88B
1-Year Est. Return 1.03%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
-1.03%
3 Year Est. Return
+41.79%
5 Year Est. Return
+147.21%
10 Year Est. Return
AUM
$1.35B
AUM Growth
+$142M
Cap. Flow
+$47.8M
Cap. Flow %
3.55%
Top 10 Hldgs %
59.62%
Holding
55
New
16
Increased
19
Reduced
9
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 31.22%
2 Consumer Discretionary 28.67%
3 Industrials 23.33%
4 Materials 7.31%
5 Communication Services 5.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BXC icon
26
BlueLinx
BXC
$422M
$10.8M 0.8%
106,000
-82,645
-44% -$9.47M
TITN icon
27
Titan Machinery
TITN
$396M
$9.67M 0.72%
684,459
+401,302
+142% +$5.81M
AMTM
28
Amentum Holdings
AMTM
$5.42B
$9.46M 0.7%
+449,818
New +$11.6M
DHI icon
29
D.R. Horton
DHI
$40B
$8.39M 0.62%
+60,000
New +$10M
BOOM icon
30
DMC Global
BOOM
$138M
$7.49M 0.56%
1,019,197
+709,413
+229% +$6.69M
CCS icon
31
Century Communities
CCS
$1.91B
$7.34M 0.55%
100,000
+39,335
+65% +$3.51M
SHC icon
32
Sotera Health
SHC
$5.09B
$6.84M 0.51%
500,000
+150,000
+43% +$2.17M
RCKT icon
33
Rocket Pharmaceuticals
RCKT
$340M
$5.3M 0.39%
+421,700
New +$6.35M
TALK icon
34
Talkspace
TALK
$874M
$3.98M 0.3%
+1,288,277
New +$3.92M
ECVT icon
35
Ecovyst
ECVT
$1.32B
$3.97M 0.3%
+519,682
New +$3.84M
CHGG icon
36
Chegg
CHGG
$110M
$2.87M 0.21%
+1,785,003
New +$3.29M
RGNX icon
37
Regenxbio
RGNX
$620M
$2.57M 0.19%
+332,814
New +$3.12M
IIIV icon
38
i3 Verticals
IIIV
$412M
$2.53M 0.19%
110,000
-670,430
-86% -$15.7M
KURA icon
39
Kura Oncology
KURA
$800M
$2.4M 0.18%
+275,000
New +$3.96M
RNTX
40
Rein Therapeutics
RNTX
$63.1M
$2.2M 0.16%
+956,195
New +$2.9M
CGEM icon
41
Cullinan Oncology
CGEM
$1.01B
$1.49M 0.11%
+122,361
New +$1.76M
ACTU
42
Actuate Therapeutics
ACTU
$26.6M
$440K 0.03%
+55,246
New +$451K
CGTX icon
43
Cognition Therapeutics
CGTX
$79.6M
$351K 0.03%
+500,000
New +$247K
IRD
44
Opus Genetics
IRD
$306M
$227K 0.02%
+190,958
New +$219K
LTRN icon
45
Lantern Pharma
LTRN
$33.6M
$160K 0.01%
+50,000
New +$171K
BRDG
46
DELISTED
Bridge Investment Group
BRDG
-1,490,000
Closed -$14.7M
INAB icon
47
IN8bio
INAB
$9.93M
-2,133
Closed -$17.3K
LEN icon
48
Lennar Class A
LEN
$19.8B
-25,825
Closed -$4.69M
ONT
49
Onterris Inc
ONT
$759M
-381,500
Closed -$10M
MHO icon
50
M/I Homes
MHO
$3.74B
-25,000
Closed -$4.28M

Similar funds

Voss Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Voss Capital held 55 positions worth $1.35B, up 12% from $1.2B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Voss Capital deployed $47.8M of net new capital in Q4 2024, opening 16 new positions and adding to 19 existing holdings. Its largest new stake was Flywire: 1,485,000 shares worth $30.6M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was i3 Verticals, an estimated $15.7M trimmed.

  • Voss Capital's largest Q4 2024 buy was Flywire: 1,485,000 shares worth $30.6M.
  • Voss Capital added most to Playa Hotels & Resorts in Q4 2024, an estimated $22M increase.
  • Voss Capital's biggest Q4 2024 reduction was i3 Verticals, cutting an estimated $15.7M.
  • Voss Capital fully exited R1 RCM Inc. Common Stock in Q4 2024, selling an estimated $36.3M.
  • Voss Capital's ten largest holdings make up 60% of its $1.35B portfolio in Q4 2024.
  • Voss Capital opened 16 new positions and closed 10 in Q4 2024.
  • Voss Capital's portfolio value rose 12% quarter-over-quarter to $1.35B.

Based on Voss Capital's 13F filing for Q4 2024, filed 13 Feb 2025.